Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ROCHE HOLDINGS AG : Berenberg reaffirms its Neutral rating

06/15/2021 | 03:14am EDT

Berenberg analyst Luisa Hector maintains his Neutral opinion on the stock. The target price remains unchanged at CHF 340.


© MarketScreener with dpa-AFX Analyser 2021
All news about ROCHE HOLDING AG
07/30ROCHE : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
07/29PTC THERAPEUTICS : Significant Improvements in Survival and Developmental Milest..
AQ
07/29ROCHE : Morningstar Lowers Price Target on Roche, Maintains Buy Recommendation
MT
07/29ROCHE : Evrysdi Meets Primary Endpoint In Infants With Spinal Muscular Atrophy
MT
07/29ROCHE : Eye Drug Accepted For Priority Review In US
MT
07/29PRESS RELEASE : FDA accepts application for -3-
DJ
07/29PRESS RELEASE : FDA accepts application for -2-
DJ
07/29PRESS RELEASE : FDA accepts application for Roche's faricimab for the treatment ..
DJ
07/29ROCHE : FDA accepts application for Roche's faricimab for the treatment of neova..
AQ
07/29FDA Accepts Application for Roche’s Faricimab for the Treatment of Neovascula..
CI
More news
Financials
Sales 2021 60 925 M 67 280 M 67 280 M
Net income 2021 14 630 M 16 156 M 16 156 M
Net cash 2021 4 746 M 5 241 M 5 241 M
P/E ratio 2021 20,5x
Yield 2021 2,68%
Capitalization 305 B 337 B 337 B
EV / Sales 2021 4,94x
EV / Sales 2022 4,79x
Nbr of Employees 101 465
Free-Float 83,4%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 350,35 CHF
Average target price 373,97 CHF
Spread / Average Target 6,74%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG13.38%337 105
JOHNSON & JOHNSON9.42%453 313
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343
ELI LILLY AND COMPANY44.22%221 348
NOVO NORDISK A/S35.94%212 048